Solution structure of Compstatin, a potent complement inhibitor

Protein Science

Volumn 7, Issue 3, 1998, Pages 619-627

  Morikis, Dimitrios ^a   Assa Munt, Nuria ^a   Sahu, Arvind ^b   Lambris, John D ^b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

C3; Complement; Complement inhibitor; NMR; Peptide; Structure calculation

Indexed keywords

ASPARTIC ACID; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPSTATIN; CYCLOPEPTIDE; GLUTAMINE; GLYCINE; LEPTIN; TRYPTOPHAN; UNCLASSIFIED DRUG; VALINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; COMPLEMENT INHIBITION; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN ISOLATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; THREE DIMENSIONAL IMAGING;

EID: 0031888668     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070311     Document Type: Article

References (61)

1. Angeletti RH, Bibbs L, Bonewald LF, Fields GB, McMurray JS, Moore WT, Stults JT. 1996. Formation of disulfide bond in an octreotide-like peptide: A multicenter study. In: Marshak DR, ed. Techniques in protein chemistry VII. San Diego, California: Academic Press. p 261.
2. Bothner-By AA, Stephens RL, Lee JM, Warren CD, Jeanloz RW. 1984. Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame. J Am Chem Soc 106:811-813.
3. Braunschweiler L, Bodenhausen G, Ernst RR. 1983. Analysis of networks of coupled spins by multiple quantum NMR. Mol Phys 48:535-560.
4. Braunschweiler L, Ernst RR. 1983. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J Magn Res 53:521-528.
5. Brünger AT. 1992. X-PLOR version 3.1. New Haven, Connecticut: Yale University Press, [http://pauli.csb.yale.edu]
6. Bystrov VF. 1976. Spin-spin coupling and the conformational states of peptide systems. Prog Nucl Magn Res Spectrosc 10:41-80.
7. Campbell AP, McInnes C, Hodges RS, Sykes BD. 1995. Comparison of NMR solution structures of the receptor binding domains of Pseudomonas aeruginosa pili strains PAO, KB7, and PAK: Implications for receptor binding and synthetic vaccine design. Biochemistry 54:16255-16268.
8. Chou PY, Fasman GD. 1977. β-Turns in proteins. J Mol Biol 115:135-175.
9. Dyson HJ, Rance M, Houghten RA, Lerner RA, Wright PE. 1988. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J Mol Biol 201:161-200.
10. Dyson HJ, Wright PE. 1991. Defining solution conformations of small linear peptides. Annu Rev Biophys Biophys Chem 20:519-538.
11. Dyson HJ, Wright PE. 1995. Antigenic peptides. FASEB J 9:37-42.
12. Ehrengruber MU, Geiser T, Deranleau DA. 1994. Activation of human neutrophils by C3a and C5a: Comparison of the effects on shape changes, chemotaxis, secretion, and respiratory burst. FEBS Lett 346:181-184.
13. Ellati SG, Dahinden CA, Church MK. 1994. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells. J Invest Dermatol 102:803-806.
14. Ember JA, Sanderson SD, Taylor SM, Kawahara M, Hugli TE. 1992. Biologic activity of synthetic analogues of C5a anaphylatoxin. J Immunol 148:3165-3173.
15. Frank MM, Fries LF. 1991. The role of complement in inflammation and phagocytosis. Immunol Today 12:322-326.
16. Gallinaro R, Cheadle WG, Applegate K, Polk HCJ. 1992. The role of the complement system in trauma and infection. Surg Gynecol Obster 174:435-440.
17. αH coupling constants on protein structure determination by NMR. J Magn Res B 104:99-103.
18. Gillinov AM, Redmond JM, Winkelstein JA, Zehr KJ, Herskowitz A, Baumgartner WA, Cameron DE. 1994. Complement and neutrophil activation during cardiopulmonary bypass: A study in the complement-deficient dog. Ann Thorac Surg 57:345-352.
19. Holers VM, Kinoshita T, Molina H. 1992. The evolution of mouse and human complement C3-binding proteins: Divergence of form but conservation of function. Immunol Today 13:231-236.
20. Hugli TE. 1990. The anaphylatoxin C3a. Curr Topica Microbiol Immunol 153:181-208.
21. Johnson BJ. 1977. Complement: A host defense mechanism ready for pharmacological manipulation? J Pharmaceut Sci 66:1367-1377.
22. Kalli KR, Hsu P, Fearon DT. 1994. Therapeutic uses of recombinant complement protein inhibitors. Springer Semin Immunopathol 15:417-431.
23. Karplus M. 1959. Contact electron-spin coupling of nuclear magnetic moments. J Chem Phys 30:11-15.
24. Kilgore KS, Friedrichs GS, Homeister JW, Lucchesi BR. 1994. The complement system in myocardial ischaemia/reperfusion injury. Cardiovasc Res 28:437-444.
25. Kim Y, Prestegard JH. 1989. Measurement of vicinal couplings from cross peaks in COSY spectra. J Magn Res 84:9-13.
26. Kumar A, Ernst RR, Wüthrich K. 1980. A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem Biophys Res Commun 95:1-6.
27. Kuszewski J, Nilges M, Brünger AT. 1992. Sampling and efficiency of metric matrix distance geometry: A novel "partial" metrication algorithm. J Biomol NMR 2:33-56.
28. Lambris JD. 1990. The third component of complement: Chemistry and biology. Berlin: Springer-Verlag.
29. Lambris JD. 1993. Chemistry, biology and phylogeny of C3. [Review]. Complement Profiles 1:16-45.
30. Laskowski RA, Rullmann JA, MacArthur MW, Kaptein R, Thornton JM. 1996. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477-486.
31. Lee B, Richards FM. 1971. The interpretation of protein structures: Estimation of static accessibility. J Mol Biol 55:379-400.
32. Matsushita M. 1996. The lectin pathway of the complement system. Microbiol Immunol 40:887-893.
33. Meri S, Pangburn MK. 1990. A mechanism of activation of the alternative complement pathway by the classical pathway - Protection of C3b from inactivation by covalent attachment to C4b. Eur J Immunol 20:2555-2561.
34. Moore WT. 1993. Integration of mass spectrometry into strategies for peptide synthesis. Biol Mass Spectrom 22:149-162.
35. Morgan BP. 1994. Clinical complementology: Recent progress and future trends. Eur J Clin Invest 24:219-228.
36. Muller-Eberhard HJ. 1992. Complement - Chemistry and pathways. In: Gallin JI, Goldstein IM, Synderman R, eds. Inflammation: Basic principles and clinical correlates, 2nd ed. New York: Raven Press.
37. Nilges M. 1993. A calculation strategy for the structure determination of symmetric dimers by NMR. Proteins Struct Fund Genet 17:297-309.
38. Nilges M, Clore GM. Gronenborn AM. 1988. Determination of three-dimensional structures of proteins from intcrproton distance data by hybrid distance geometry-dynamical simulated annealing calculations. FEBS Lett 229:317-324.
39. Pekna M, Nilsson L, Nilssonekdahl K, Nilsson UR, Nilsson B. 1993. Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction. Clin Exp Immunol 91:404-409.
40. Plateau P, Guéron M. 1982. Exchangeable proton NMR without baseline distortion, using new strong-pulse sequences. J Am Chem Soc 104:7310-7311.
41. Qin J, Clore GM, Kennedy WP, Kuszewski J, Gronenborn AM. 1996. The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Structure 4:613-620.
42. Ramachandran GN, Ramakrishnan C, Sasisekharan V. 1963. Stereo-chemistry of polypeptide chain configurations. J Mol Biol 7:95-99.
43. 1H NMR spectra of proteins via double quantum filtering. Biochem Biophys Res Commun 117:479-485.
44. Robbins RA, Russ WD, Rasmussen JK, Clayton MM. 1987. Activation of the complement system in the adult respiratory distress syndrome. Am Rev Respir Dis 135:651-658.
45. Reid KBM, Turner MW. 1994. Mammalian lectins in activation and clearance mechanisms involving the complement system. Springer Semin Immunopathol 15:307-326.
46. Reynard AM. 1980. The regulation of complement activity by pharmacologic agents. J Immunopharmacol 2:1-47.
47. Richardson JS. 1981. The anatomy and taxonomy of protein structure. Adv Protein Chem 34:167-339.
48. Rose GD, Gierash LM, Smith JA. 1985. Turns in peptides and proteins. Adv Protein Chem 37:1-109.
49. Sahu AB, Kay BK, Lambris JD. 1996. Inhibition of human complement by a C3-binding peptide isolated from a phage displayed random peptide library. J Immunol 157:884-891.
50. Sahu A, Pangburn MK. 1996. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3. Biochem Pharmacol 51:797-804.
51. Sattler M, Liang H, Nettesheim D, Meadows RP, Harlan JE, Eberstadt M, Yoon HS, Shuker SB, Chang BS, Minn AJ, Thompson CB, Fesik SW. 1997. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis. Science 275:983-986.
52. Schulz GE, Schirmer RH. 1979. Principles of protein structure. New York: Springer Verlag.
53. Vasthare US, Rosenwasser RH, Barone FC, Tuma RF. 1993. Involvement of the complement system in cerebral ischemic and reperfusion injury. FASEB J 7:A424.
54. Venkatachalam CM. 1968. Conformation of a system of three linked peptide units. Biopolymers 6:1425-1436.
55. Wang AC, Bax A. 1996. Determination of the backbone dihedral angles φ in human ubiquitin from reparametrized empirical Karplus equations. J Am Chem Soc 118:2483-2494.
56. Wang MW, Johnston PS, Wright LJ, Lim SML, White DJG. 1992. Immunofluorescent localization of pig complement component-3, regardless of the presence or absence of detectable immunoglobulins, in hyperacutely rejected heart xenografts. Histochem J 24:102-109.
57. Weber C, Wider G, von Freyberg B, Traber R, Braun W, Widmer H, Wüthrich K. 1991. The NMR structure of cyclosporine A bound to cyclophilin in aqueous solution. Biochemistry 30:6563-6574.
58. Wilmot CM, Thornton JM. 1988. Analysis and prediction of the different types of β-turn in proteins. J Mol Biol 203:221-212.
59. Wishart DS, Sykes BD, Richards FM. 1991. Relationship between nuclear magnetic resonance chemical shift and protein secondary structure. J Mol Biol 222:311-333.
60. Wüthrich K. 1986. NMR of proteins and nucleic acids. New York: John Wiley and Sons.
61. Wüthrich K, von Freyberg B, Weber C, Wider G, Traber R, Widmer H, Braun W. 1991. Receptor-induced conformation change of the immunosuppressant cyclosporin A. Science 254:953-954.